JP2013507127A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507127A5
JP2013507127A5 JP2012533270A JP2012533270A JP2013507127A5 JP 2013507127 A5 JP2013507127 A5 JP 2013507127A5 JP 2012533270 A JP2012533270 A JP 2012533270A JP 2012533270 A JP2012533270 A JP 2012533270A JP 2013507127 A5 JP2013507127 A5 JP 2013507127A5
Authority
JP
Japan
Prior art keywords
variation
locus
snp
allele
lupus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012533270A
Other languages
English (en)
Japanese (ja)
Other versions
JP5937008B2 (ja
JP2013507127A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/051589 external-priority patent/WO2011044205A1/en
Publication of JP2013507127A publication Critical patent/JP2013507127A/ja
Publication of JP2013507127A5 publication Critical patent/JP2013507127A5/ja
Application granted granted Critical
Publication of JP5937008B2 publication Critical patent/JP5937008B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012533270A 2009-10-07 2010-10-06 ループスの治療、診断、モニタリング方法 Expired - Fee Related JP5937008B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27851009P 2009-10-07 2009-10-07
US61/278,510 2009-10-07
PCT/US2010/051589 WO2011044205A1 (en) 2009-10-07 2010-10-06 Methods for treating, diagnosing, and monitoring lupus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016095330A Division JP6321717B2 (ja) 2009-10-07 2016-05-11 ループスの治療、診断、モニタリング方法

Publications (3)

Publication Number Publication Date
JP2013507127A JP2013507127A (ja) 2013-03-04
JP2013507127A5 true JP2013507127A5 (enExample) 2014-04-10
JP5937008B2 JP5937008B2 (ja) 2016-06-22

Family

ID=43857111

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012533270A Expired - Fee Related JP5937008B2 (ja) 2009-10-07 2010-10-06 ループスの治療、診断、モニタリング方法
JP2016095330A Expired - Fee Related JP6321717B2 (ja) 2009-10-07 2016-05-11 ループスの治療、診断、モニタリング方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016095330A Expired - Fee Related JP6321717B2 (ja) 2009-10-07 2016-05-11 ループスの治療、診断、モニタリング方法

Country Status (9)

Country Link
US (3) US20130034544A1 (enExample)
EP (3) EP3219813B1 (enExample)
JP (2) JP5937008B2 (enExample)
KR (2) KR101953075B1 (enExample)
CN (2) CN113025703A (enExample)
BR (1) BR112012007778A2 (enExample)
CA (1) CA2777055C (enExample)
RU (2) RU2016131167A (enExample)
WO (1) WO2011044205A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113025703A (zh) 2009-10-07 2021-06-25 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
WO2012031122A2 (en) * 2010-09-03 2012-03-08 Immport Therapeutics, Inc. Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
KR20140034529A (ko) 2012-09-12 2014-03-20 삼성전기주식회사 전기 동도금 장치
KR101491214B1 (ko) * 2012-10-10 2015-02-06 가톨릭대학교 산학협력단 １ｑ２５．１(RABGAP1L) 위치, 6p21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물
WO2014058254A1 (ko) * 2012-10-10 2014-04-17 가톨릭대학교 산학협력단 １ｑ２５．１(RABGAP1L) 위치, 6P21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물
CN106460054A (zh) * 2014-03-21 2017-02-22 新加坡科技研究局 癌症中的融合基因
DE102017107661A1 (de) 2017-04-10 2018-10-11 Universität Rostock SH2B-Adapterprotein-3 für die Vorhersage einer Knochenmarkantwort und Immunantwort
KR20190034511A (ko) 2019-03-22 2019-04-02 아주대학교산학협력단 Aimp1을 포함하는 전신 홍반성 루프스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루프스 진단 방법
US20230054595A1 (en) * 2019-12-18 2023-02-23 The Children's Hospital Of Philadelphia Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same
JP7162406B1 (ja) * 2021-07-15 2022-10-28 富士フイルム株式会社 細胞の品質管理方法及び細胞を製造する方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683203A (en) 1984-04-14 1987-07-28 Redco N.V. Immobilized enzymes, processes for preparing same, and use thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
JP4312259B2 (ja) 1995-04-27 2009-08-12 アムジェン フレモント インク． 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
EP2369007B1 (en) 1996-05-29 2015-07-29 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
DE69738539T2 (de) 1996-12-03 2009-03-26 Amgen Fremont Inc. Vollkommen humane Antikörper die EGFR binden
AU6534600A (en) * 1999-08-09 2001-03-05 Uab Research Foundation Genetic polymorphism in the il-10 promoter
EP1313880A2 (en) 2000-05-30 2003-05-28 PE Corporation (NY) Methods for detecting target nucleic acids using coupled ligation and amplification
WO2002018414A2 (en) * 2000-08-29 2002-03-07 Genaissance Pharmaceuticals, Inc. Haplotypes of the bf gene
US6900016B1 (en) 2000-09-08 2005-05-31 Applera Corporation Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
CA2426540A1 (en) 2000-10-20 2002-07-25 Biocardia, Inc. Leukocyte expression profiling
US7205106B1 (en) 2001-07-20 2007-04-17 Roche Molecular Systems, Inc. Association of polymorphisms in IL4-related genes with autoimmune disease
JP2003061677A (ja) 2001-08-28 2003-03-04 Olympus Optical Co Ltd 全身性エリテマトーデスの感受性遺伝子およびその使用
US20030119004A1 (en) 2001-12-05 2003-06-26 Wenz H. Michael Methods for quantitating nucleic acids using coupled ligation and amplification
US7022476B2 (en) 2002-02-26 2006-04-04 New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
US20050026173A1 (en) * 2003-02-27 2005-02-03 Methexis Genomics, N.V. Genetic diagnosis using multiple sequence variant analysis combined with mass spectrometry
WO2004083403A2 (en) 2003-03-18 2004-09-30 Applera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2005086872A2 (en) 2004-03-10 2005-09-22 Celera, An Applera Corporation Business Ptpn22 polymorphisms in diagnosis and therapy
DE102005003686A1 (de) 2005-01-26 2006-08-03 Rohde & Schwarz Gmbh & Co. Kg Anordnung zum Glätten des einem Verbraucher zugeführten Verbraucherstromes
BRPI0614183A2 (pt) * 2005-07-25 2011-03-15 Trubion Pharmaceuticals Inc uso de dose única de moléculas de ligação especìficas para cd20
EP1945800B1 (en) 2005-08-05 2012-03-14 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
US20070238094A1 (en) * 2005-12-09 2007-10-11 Baylor Research Institute Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
CN101374964B (zh) * 2005-12-09 2013-07-17 贝勒研究院 外周血液白细胞转录模式的模块水平分析
CN101443040A (zh) * 2006-03-16 2009-05-27 基因技术股份有限公司 用cd4抗体治疗狼疮的方法
KR20080112300A (ko) 2006-03-16 2008-12-24 제넨테크, 인크. Ｃｄ4 항체를 사용하여 루푸스를 치료하는 방법
US20070269827A1 (en) 2006-05-18 2007-11-22 Oklahoma Medical Research Foundation Predicting and Diagnosing Patients With Autoimmune Disease
WO2008033239A2 (en) * 2006-09-11 2008-03-20 Applera Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
WO2008087647A2 (en) * 2007-01-19 2008-07-24 Yeda Research And Development Co. Ltd. Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
US7695916B2 (en) * 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
AU2008254582A1 (en) * 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
WO2009015087A2 (en) * 2007-07-20 2009-01-29 Potentia Pharmaceuticals, Inc. Compositions and methods for treatment of trauma
US8008013B2 (en) * 2007-11-16 2011-08-30 Oklahoma Medical Research Foundation Predicting and diagnosing patients with autoimmune disease
EP2227780A4 (en) * 2008-03-19 2011-08-03 Existence Genetics Llc GENETIC ANALYSIS
DE102008031958A1 (de) 2008-07-07 2010-01-14 Klebchemie M.G. Becker Gmbh & Co. Kg Verfahren zum Laminieren von Hochglanzoberflächen
CA2736373A1 (en) * 2008-09-26 2010-04-01 Timothy W. Behrens Methods for treating, diagnosing, and monitoring lupus
CN113025703A (zh) 2009-10-07 2021-06-25 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法

Similar Documents

Publication Publication Date Title
JP2013507127A5 (enExample)
JP2010528590A5 (enExample)
CN107475371B (zh) 发现药物基因组生物标志物的方法
JP2012503985A5 (enExample)
RU2012118596A (ru) Способы лечения, диагностики и мониторинга волчанки
JP2018038436A5 (enExample)
JP2022173308A (ja) エンザスタウリンの活性を予測するための方法および組成物
RU2009147281A (ru) Способы и композиции для диагностики и лечения волчанки
JP2011520433A5 (enExample)
WO2013160315A2 (en) Genetic predictors of response to treatment with crhr1 antagonists
JP2008523844A5 (ja) ワルファリンの投与範囲を予想する方法
JP2011530312A5 (enExample)
JP5899527B2 (ja) 第６染色体短腕２１．３３領域の一塩基多型に基づく抗てんかん薬による薬疹リスクの検査方法
JP2017511138A5 (enExample)
JP2013520185A (ja) レビー小体認知症診断の遺伝子マーカー
JP2010510804A5 (enExample)
JP6905468B2 (ja) Ｃｒｈｒ１拮抗薬を用いた治療に対する反応の遺伝子予測因子を用いた治療の方法
CN106399582B (zh) 一种检测与结直肠癌靶向用药西妥昔单抗治疗敏感性相关基因的多态性的试剂盒及其应用
KR102158673B1 (ko) 양극성장애 환자의 계절성 또는 일주기 변화 진단을 위한 단일염기다형성 마커를 이용한 정보 제공 방법
KR20230005816A (ko) 신경전달물질 수송체 억제제의 효능을 평가하기 위한 조성물 및 방법
JP2016512950A (ja) 抗精神病薬に基づく処置により誘導される錐体外路症状（ｅｐｓ）の発症を予測する方法
JP2018511318A (ja) Ｃｒｈｒ１拮抗薬を用いた治療に対する反応の遺伝子予測因子
WO2020182189A1 (en) Methods for detecting or reducing the incidence of adverse drug reactions
EP3315613B1 (en) Methods and kits for diagnosing or assessing the risk of cervical cancer
KR20230045092A (ko) 설폰아마이드 유도체 계의 항전간제에 의해 유발되는 약물 과민 반응을 검출하는 방법 및 키트, 및 키트의 용도